ETFMG Treatments Testing and Advancements ETF (GERM) ETF

Expense Ratio: 0.68% | AUM: 58.44M | Issuer: ETF Managers Group

GERM Daily Price Range
GERM 52-Week Price Range

GERM - Real-Time SMART Grade™

NR
Not Rated

Overall SMART Grade

GERM has a real-time SMART Grade of NR (Not Rated).

Learn More About SMART Grades™

GERM - Profile & Info


The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index. The fund invests at least 80% of its total assets in the component securities of the index. The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund is non-diversified.

Issuer ETF Managers Group
Expense Ratio 0.68%
Assets Under Management (AUM) 58.44M
Underlying Index Prime Treatments, Testing and Advancements Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $37.70
Options? Yes
Total Holdings 69

GERM - Top Holdings

Symbol Holding Name % of Total
LH Laboratory Corp Of Amer 6.16%
NVAX Novavax Inc 6.02%
VIR VIR BIOTECHNOLOGY INC 5.80%
BIO Bio Rad Laboratories Inc 5.33%
MRNA Moderna Inc 4.97%
DGX QUEST DIAG 4.75%
BNTX BioNTech SE 4.64%
ZLAB Zai Lab Ltd 4.59%
AVIR ATEA PHARMACEUTICALS INC 4.34%
ADPT Adaptive Biotechnologies 3.98%
ALNY Alnylam Pharmaceuticals 3.80%
EBS EMERGENT BIOSO 3.70%
CVAC CUREVAC N V 3.09%
IMAB I MAB 3.03%
QDEL Quidel Corp 2.75%
NK NantKwest Inc 2.57%
OPK OPKO Health Inc 2.19%
DRNA DICERNA PHARMA 1.47%
BCRX BioCryst Pharmaceuticals Inc 1.38%
INO Inovio Pharmaceuticals Inc 1.37%
TBIO Translate Bio Inc 1.26%
VBIV VBI VACCINES INC CDA 1.19%
LMNX Luminex Corp 1.10%
ARCT ARCTURUS THERAPEUTICS HLDGS 0.94%
PCVX VAXCYTE INC 0.87%
ALGS ALIGOS THERAPEUTICS INC 0.80%
LLY Lilly Eli & Co 0.80%
Cash&Other Cash & Other 0.75%
ENTA ENANTA PHARMAC 0.72%
ALXN Alexion Pharmaceuticals 0.71%
DVAX DYNAVAX TECHNO 0.70%
VIVO Meridian Bioscience Inc 0.66%
ABT Abbott Laboratories 0.62%
JNJ Johnson & Johnson 0.60%
ABBV AbbVie Inc 0.58%
GILD GILEAD SCI 0.57%
VXRT Vaxart Inc 0.57%
BMY Bristol-Myers Squibb Co 0.56%
HOLX Hologic Inc 0.56%
OSUR OraSure Technologies Inc 0.55%
AZN ASTRAZENECA PLC 0.51%
GSK GlaxoSmithKline PLC 0.51%
REGN Regeneron Pharmaceuticals Inc 0.51%
SNY Sanofi 0.51%
TAK TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS 0.51%
CVM CEL-SCI Corp. 0.50%
MRK MERCK & CO 0.50%
PFE Pfizer Inc 0.47%
CMRX Chimerix Inc 0.45%
OXFD Oxford Immunotec Global Plc 0.41%
XBIT XBiotech Inc 0.40%
SIGA SIGA Technologies Inc 0.36%
CRMD CORMEDIX INC 0.35%
CUE CUE BIOPHARMA INC 0.30%
ATHX ATHERSYS INC NEW 0.29%
CODX CO-DIAGNOSTICS INC 0.28%
SQZ SQZ BIOTECHNOLOGIES CO 0.26%
PRTK Paratek Pharmaceuticals Inc 0.25%
ABUS ARBUTUS BIOPHARMA CORP 0.23%
IBIO iBio Inc 0.23%
CDAK CODIAK BIOSCIENCES INC 0.22%
HOOK HOOKIPA Pharma Inc 0.22%
IMV IMV INC 0.16%
ASMB ASSEMBLY BIOSCIENCES INC 0.12%
ENOB Enochian Biosciences Inc 0.12%
CFRX CONTRAFECT CORP 0.11%
ENZ ENZO BIOCHEM 0.10%
PHAS PhaseBio Pharmaceuticals Inc 0.08%
GERM ETFMG Treatments Testing and Adv ETF 0.00%

GERM - Price/Volume Stats

Current price $35.70
Prev. close $37.70
Day low $35.27
Day high $36.82
52-week high $44.69
52-week low $23.80
Day Volume 52,810
Avg. volume 35,800
Dividend yield 0.76%

GERM - Recent Returns

1-mo -14.72%
3-mo 8.01%
6-mo 45.04%
1-year N/A
3-year N/A
5-year N/A
YTD 14.79%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

GERM - Stock Chart


GERM - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

Most Popular Articles



9 'MUST OWN' Growth Stocks for 2021
Page generated in 1.8211 seconds.